Tuberculosis (TB) is still a prevalent disease, one third of the population is infected by *mycobacterium tuberculosis (MT)*.Treatment with anti TNF therapies appears to increase the risk for developing TB

Aim
===

To study the occurrence of latent TB (LTB) or tuberculosis disease (TBD) in children with JIA under anti TNF therapy.

Methods
=======

Clinical records from pts with JIA ( ILARÂ´01) under anti-TNF therapy were reviewed, focusing on TB screening prior to biologicals , PPD conversion or TBD diagnosiss.LTB was considered as a PPD (TST) positive (≥ 5 mm), in the abscense of radiological manifestations of TB.

Results
=======

105 JIA pts received one or more anti TNF drugs during the observation. Four of them developed LTB and 3 others TBD.

         Gender/ age( ys)   Dx     PPD (mm)\*   TBDisease              antiTNF   Time under 1st Biologic   TB tx     2nd Biological Tx
  ------ ------------------ ------ ------------ ---------------------- --------- ------------------------- --------- -------------------
  Pt 1   M / 18             pJIA   18           no                     ETN       24 m                      INH       No
  Pt 2   F/ 20              oJIA   12           no                     ADA       24 m                      INH       No
  Pt 3   F / 7              pJIA   6            no                     ETN       11 m                      INH       INF
  Pt 4   M / 13             sJIA   13           no                     IFX       1 m                       INH       No
  Pt 5   F / 14             pJIA   10           Pulmonar involvement   IFX       6 m                       4 drugs   ETN
  Pt 6   F / 17             pJIA   13           Pulmonar involvement   IFX       24 m                      4 drugs   No
  Pt 7   F / 12             pJIA   13           Pulmonar involvement   ETN       30 m                      4 drugs   ETN

No extrapulmonar TB or miliary forms were observed. All patients were PPD negative prior to biological agents

Conclusions
===========

No significative difference was found between specific anti TNF and the occurrence of LTB or TBD. In 4 pts, the infectious event occurred after 2 ys of exposure and in two earlier as described in the literature. This data highlights the importance of TB surveillance prior to and during anti-TNF therapy.
